Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
- PMID: 24355989
- DOI: 10.1038/nrm3722
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Abstract
The BCL-2 protein family determines the commitment of cells to apoptosis, an ancient cell suicide programme that is essential for development, tissue homeostasis and immunity. Too little apoptosis can promote cancer and autoimmune diseases; too much apoptosis can augment ischaemic conditions and drive neurodegeneration. We discuss the biochemical, structural and genetic studies that have clarified how the interplay between members of the BCL-2 family on mitochondria sets the apoptotic threshold. These mechanistic insights into the functions of the BCL-2 family are illuminating the physiological control of apoptosis, the pathological consequences of its dysregulation and the promising search for novel cancer therapies that target the BCL-2 family.
Similar articles
-
Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities.Clin Exp Pharmacol Physiol. 2004 Mar;31(3):119-28. doi: 10.1111/j.1440-1681.2004.03975.x. Clin Exp Pharmacol Physiol. 2004. PMID: 15008953 Review.
-
BH3-only proteins in apoptosis and beyond: an overview.Oncogene. 2008 Dec;27 Suppl 1(Suppl 1):S2-19. doi: 10.1038/onc.2009.39. Oncogene. 2008. PMID: 19641503 Free PMC article. Review.
-
Dual-site interactions of p53 protein transactivation domain with anti-apoptotic Bcl-2 family proteins reveal a highly convergent mechanism of divergent p53 pathways.J Biol Chem. 2013 Mar 8;288(10):7387-98. doi: 10.1074/jbc.M112.400754. Epub 2013 Jan 11. J Biol Chem. 2013. PMID: 23316052 Free PMC article.
-
BIM and other BCL-2 family proteins exhibit cross-species conservation of function between zebrafish and mammals.Cell Death Differ. 2008 Jun;15(6):1063-72. doi: 10.1038/cdd.2008.42. Epub 2008 Apr 11. Cell Death Differ. 2008. PMID: 18404156 Free PMC article.
-
Targeting the BH3 domain of Bcl-2 family proteins. A brief history from natural products to foldamers as promising cancer therapeutic avenues.Curr Med Chem. 2013;20(24):2964-78. doi: 10.2174/0929867311320240003. Curr Med Chem. 2013. PMID: 23746270 Review.
Cited by
-
Breathing new insights into the role of mutant p53 in lung cancer.Oncogene. 2024 Nov 20. doi: 10.1038/s41388-024-03219-6. Online ahead of print. Oncogene. 2024. PMID: 39567755 Review.
-
Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope.Mol Cancer. 2024 Nov 15;23(1):255. doi: 10.1186/s12943-024-02130-8. Mol Cancer. 2024. PMID: 39543600 Free PMC article. Review.
-
Osteosarcoma cells depend on MCL-1 for survival, and osteosarcoma metastases respond to MCL-1 antagonism plus regorafenib in vivo.BMC Cancer. 2024 Nov 4;24(1):1350. doi: 10.1186/s12885-024-13088-7. BMC Cancer. 2024. PMID: 39497108 Free PMC article.
-
Deciphering the topological landscape of glioma using a network theory framework.Sci Rep. 2024 Nov 5;14(1):26724. doi: 10.1038/s41598-024-77856-y. Sci Rep. 2024. PMID: 39496747 Free PMC article.
-
Regulated Cell Death Pathways in Pathological Cardiac Hypertrophy.Rev Cardiovasc Med. 2024 Oct 11;25(10):366. doi: 10.31083/j.rcm2510366. eCollection 2024 Oct. Rev Cardiovasc Med. 2024. PMID: 39484135 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources